Johnson and Johnson Stock Price - JNJ

-0.16 (-0.13%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Johnson and Johnson JNJ NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-3.41 -2.69% 123.16 120.58 127.62 121.50 126.57 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
115,411 12,163,272 $ 123.37 $ 1,500,545,404 13,848,618 109.16 - 154.50
Last Trade Time Type Quantity Stock Price Currency
19:59:28 formt 100 $ 123.00 USD

Johnson and Johnson Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 324.69B 2.64B $ 15.30B 5.63 22.50 2.63B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
20.34M $ 3.75 3.04% 02/24/20 - -

more financials information »

Johnson and Johnson News

Loading Messages....

Latest JNJ Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JNJ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week127.39131.00109.16118.7816,850,622-4.23-3.32%
1 Month135.36143.64109.16129.1416,307,629-12.20-9.01%
3 Months143.50154.50109.16137.5910,261,018-20.34-14.17%
6 Months128.61154.50109.16136.338,556,834-5.45-4.24%
1 Year138.57154.50109.16135.657,789,309-15.41-11.12%
3 Years125.16154.50109.16134.156,680,675-2.00-1.6%
5 Years100.28154.5081.79123.656,632,19122.8822.82%

Johnson and Johnson Description

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.